Hook - Teradyne is no longer just a test-equipment vendor waiting for the next capex cycle. Over the last year the business has tilted decisively toward AI-driven demand, and that market change is showing up in revenue composition, guidance, and valuation support. Q2 prints and updated guidance suggest AI-related testing is moving from cyclical to structural for Teradyne.
Thesis - Buy Teradyne on a controlled pullback around $370 with a 180-trading-day horizon. The company reported strong Q2 results and raised guidance, AI now makes up a majority of sales, and Teradyne's balance sheet and cash generation provide optionality for product investment and M&A. Even after the run from 2025 lows, the risk/reward looks attractive if you accept a temporarily rich multiple in exchange for high-growth revenue and strong free cash flow.
What the company does and why the market should care
Teradyne designs and sells automatic test systems across three segments - Semiconductor Test, Robotics, and All Other. Semiconductor Test is the cash engine: buyers of memory and AI accelerator chips must validate devices at scale before deployment, and that testing is becoming more complex and volume-intensive because of AI model demands. The Robotics segment provides additional upside via collaborative robotic arms and autonomous mobile robots used in factories and warehouses. The market cares because Teradyne is uniquely positioned at the intersection of booming AI compute demand and factory automation.
Concrete signals that this is more than a cyclical uptick:
- Management reported Q2 adjusted EPS of $2.47 on $1.33B revenue and followed with Q3 revenue guidance of $1.2-1.3B alongside adjusted EPS guidance of $1.85-2.15 - both well above consensus. The market reacted positively to the beats and the strong forward guide (reported 07/29/2026).
- Management has said AI now drives roughly 70% of revenue, with year-over-year revenue growth in the high double digits - a durable shift in demand profile (reported 04/30/2026).
- Free cash flow is meaningful: the latest annualized free cash flow figure is $799,932,000, providing firepower for R&D and optionality for capital allocation.
Key balance sheet and valuation context
| Metric | Value |
|---|---|
| Current price | $372.17 |
| Market cap | $56.77B |
| Enterprise value | $56.42B |
| EPS (TTM) | $7.36 |
| P/E | ~49 |
| Free cash flow | $799.93M |
| ROE / ROA | 33.46% / 23.35% |
| 52-week range | $109.56 - $487.91 |
| Current ratio | 2.12 |
Valuation is rich on a trailing multiple basis - P/E sits near 49 and price-to-sales is elevated - but that premium is partly justified by high profitability (ROE 33%) and rapid top-line growth as AI becomes a dominant end market. With an enterprise value around $56.4B and nearly $800M in free cash flow, the EV/FCF multiple is elevated but not irrational for a company demonstrating structural revenue expansion.
Technical and sentiment overlay
From a technical perspective, the stock is trading below short- and medium-term moving averages - 10-day SMA $390.97, 20-day $385.66, 50-day $383.58 - which signals short-term consolidation after a strong run. Momentum indicators are neutral to slightly negative (RSI 45; MACD histogram negative), so some patience on timing is prudent. Short interest and recent short-volume prints show episodic selling pressure, but days-to-cover remain low (around 2-2.6 days), reducing the likelihood of a sustained squeeze.
Catalysts
- Continued AI-driven revenue growth and product ramps in semiconductor test - evidence already present in Q2 beats and elevated AI revenue share.
- Index inclusion benefits - the stock was added to the Nasdaq-100 effective 06/22/2026, which supports passive flows and liquidity.
- Robotics adoption in industrial automation and fulfillment centers - incremental revenue diversification outside pure semiconductor spending.
- Further guide-ups from management or bullish commentary from large OEM customers around AI accelerator deployments and memory testing demand spikes.
Trade plan (actionable)
Entry: $370.00 (limit order) - place order on a pullback or on intraday weakness; current market price is $372.17.
Stop loss: $330.00 - a hard stop below recent consolidation and below several shorter-term moving averages; protects capital if cyclicality re-emerges.
Target: $460.00 - primary target for the trade over a long-term horizon.
Horizon: This is a long-term trade - 180 trading days - because structural demand shifts and product ramps take time to manifest in consistent results. However, plan two legs: a nearer-term profit-taking point around $420 within 45 trading days if the stock re-tests prior short-term resistance, and the larger objective to $460 over 180 trading days as AI-related testing volumes and robotics traction continue to compound.
Position sizing guidance: treat this as a medium-risk position - consider 2-5% of portfolio exposure depending on risk tolerance. Use the $330 stop to size the position such that the dollar-risk matches your risk budget.
Risks and counterarguments
- Valuation compression: The stock trades at a P/E near 49. If growth slows or guidance misses, multiple contraction could produce meaningful downside even if revenue remains positive.
- Cyclicality and lumpiness: Semiconductor equipment and test spending is inherently lumpy. Large customer timing shifts could cause sequential downgrades despite a favorable long-term trend.
- Concentration risk: A handful of hyperscalers and memory makers account for a disproportionate share of AI-related capex. If those buyers slow spending or favor vertical integration, Teradyne’s growth could underperform expectations.
- Execution in Robotics: Robotics is a promising diversification, but scaling commercial traction and integrating software systems across factories takes time and investment; weak execution would dent investor optimism.
- Macro/Rate risk: Higher interest rates and macro slowdowns can reduce capex and delay purchases of expensive test equipment, increasing working capital and inventory risks for Teradyne and its customers.
Counterargument: The bear case is straightforward - investors can argue that Teradyne is already priced for perfection. A near-50x P/E implies sustained high growth and margin expansion. If AI demand consolidates among a smaller set of suppliers or memory capex turns down, the multiple could retrace sharply and make the risk/reward unattractive.
What would change my mind
I would downgrade this trade if one or more of the following occurred:
- Management issues conservative guidance for the next two quarters that implies lower-than-expected AI-driven demand.
- Margins show sustained deterioration due to pricing pressure or higher warranty/service costs in the test business.
- Macro indicators tied to semiconductor capex (memory pricing, foundry utilization) point to an extended downturn.
- Price breaks and holds below $330 on heavy volume, signaling technical failure and higher probability of further downside.
Conclusion
Summary stance - I am constructive on Teradyne and recommend a tactical buy around $370 with a $330 stop and a $460 target over 180 trading days. The combination of Q2 outperformance, growing AI-driven revenue (management cites roughly 70% of revenue), strong free cash flow of roughly $800M, and Nasdaq-100 inclusion create a multi-quarter growth runway. That said, valuation is elevated and the trade requires discipline - both in sizing and stops - because the business remains exposed to semiconductor cyclicality and execution risk in robotics.
Actionable checklist: enter $370.00 limit, stop $330.00, primary take-profit $460.00 (180 trading days), consider partial profit near $420 within 45 trading days. Re-evaluate on the next two quarterly updates and if price action invalidates the technical stop.